Position Papers and Guidelines

Below are all of the current ABCD Position Papers and Guidelines.

🔴 It is the responsibility of the reader to ensure that any data that they use from these resources has not been superseded by new information / guidance.

1 - 10 of 10

Title	Resource Type	Clinical Area	Published
Discontinuation of Levemir (insulin detemir): Joint guidance from ABCD and PCDO Society	Guidelines - ABCD	Type 1 diabetes mellitus	2025
Finerenone in the management of Diabetic Kidney Disease: A consensus statement by the Association of British Clinical Diabetologists and UK Kidney Association	Position Paper	Chronic kidney disease, Type 2 diabetes mellitus	2025
Clinical practice guidelines for management of lipids in adults with diabetic kidney disease	Guidelines - ABCD	Chronic kidney disease, Transitional diabetes care, Treatments for diabetes, Type 1 diabetes mellitus, Type 2 diabetes mellitus	2024
Joint ABCD and PCDS guidance: GLP-1 receptor agonist national shortage	Guidelines - ABCD	Treatments for diabetes, Type 1 diabetes mellitus, Type 2 diabetes mellitus	2023
Best Practice Guide for hybrid closed-loop therapy	Diabetes Technology Network (DTN-UK), Guidelines - ABCD	Hybrid-closed loop therapy, Pumps and pump technology, Type 1 diabetes mellitus, Type 2 diabetes mellitus	2023
Management of Hypertension in Patients With Diabetic Kidney Disease: Summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2021	Guidelines - ABCD	Treatments for diabetes, Type 1 diabetes mellitus, Type 2 diabetes mellitus	2022
ABCD and Renal Association Standards of Care for Glycaemic Assessment in People with Diabetes on Haemodialysis	Guidelines - ABCD	Type 1 diabetes mellitus, Type 2 diabetes mellitus	2021
ABCD and Renal Association Clinical practice guidelines for management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease (DKD)	Guidelines - ABCD	Chronic kidney disease, Diabetic nephropathy, Treatments for diabetes, Type 1 diabetes mellitus, Type 2 diabetes mellitus	2021
SGLT-2 inhibitors in people with type 2 diabetes	Education, Position Paper	Type 2 diabetes mellitus	2020
ABCD position statement on the use of sodium-glucose cotransporter-2 inhibitors in type 1 diabetes (updated 2019)	Position Paper	Type 1 diabetes mellitus	2019